NYSE$PRI
Primerica Inc · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Primerica's financial performance declined in Q2 2022, with EPS decreasing by 13% and net income by 16%, while facing challenges in the Investment and Savings segment due to market correction.
Primerica's Q2 2022 results showed a mixed performance. While total revenues increased by 2%, net income and EPS decreased by 16% and 13%, respectively. The Term Life segment remained strong, but the Investment and Savings segment was impacted by market correction. The company is focusing on sales force momentum and anticipates a better second half of the year.
- New life licenses increased by 14%, driving the sales force to 132,149 representatives.
- Term Life net premiums increased by 7%, with adjusted direct premiums increasing by 8%.
- Investment and Savings Products sales reached $2.7 billion, with net client inflows of $0.9 billion.
- Net earnings per diluted share (EPS) of $2.79 declined 13%, and return on stockholders’ equity (ROE) was 23.3%.
Headline financials
Revenue & EPS history
Primerica · Revenue · Quarterly
$669M
Revenue by segment
Primerica · $660M total across 3 segments · Q2 2022
- Term Life Insurance$411M+7.1%62.2%
- Investment and Savings Products$222M-6.6%33.7%
- Corporate and Other Distributed Products$26.9M-17.5%4.1%
Forward guidance
Primerica is encouraged by the momentum in its sales force and expects benefits from improvements in the licensing process and excitement generated during the convention. The company believes it is well-positioned for the second half of the year.
Tailwinds
- Momentum in sales force is encouraging.
- Improvements in licensing process are showing real benefits.
- Excitement generated during the convention will fuel momentum.
- Company anticipates continued growth from recruiting and licensing.
- Strong balance sheet including invested assets and cash at the holding company of $232 million at quarter-end.
Headwinds
- Senior Health segment continued to face headwinds as the industry adjusts to higher churn rates and the need to lower contract acquisition costs.
- Closed U.S. Mortgage Volume ($ million brokered) decreased 49%.
- Insurance expenses increased $11.1 million, or 23% year-over-year, with more than half of the increase due to adding the previously postponed biennial convention.
- The segment recorded an adjusted operating loss before taxes of $21.9 million, increasing $5.0 million year-over-year.
- COVID claims continued to decline and were $2 million net of reinsurance for the quarter.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2022
+0.5%
Avg return
Earnings day
+2.0%
Avg return
5 days after
+1.1%
Avg return
30 days after
53%
34 / 64 earnings
Positive
+22.3%
Q3 2016
Best reaction
-14.0%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.4% | -1.2% | -4.1% | |
| Q4 2025 | -1.3% | +2.3% | -1.7% | |
| Q3 2025 | -2.1% | +0.2% | -0.8% | |
| Q1 2025 | +2.3% | +1.7% | +1.8% | |
| Q4 2024 | -3.9% | -3.1% | -1.6% | |
| Q3 2024 | +5.0% | +8.6% | +6.8% | |
| Q2 2024 | +3.4% | +4.5% | +5.8% | |
| Q1 2024 | +0.6% | +2.7% | +3.5% | |
| Q4 2023 | +0.4% | +3.3% | +2.9% | |
| Q3 2023 | +0.7% | +1.6% | +3.0% | |
| Q2 2023 | +0.5% | -0.3% | -6.7% | |
| Q1 2023 | -1.2% | -0.7% | +5.5% | |
| Q4 2022 | +9.0% | +15.4% | -2.3% | |
| Q3 2022 | -3.2% | -2.7% | -1.2% | |
| Q2 2022 | +0.1% | +6.4% | -4.0% | |
| Q1 2022 | -14.0% | -11.5% | -7.5% | |
| Q4 2021 | -10.7% | -11.9% | -14.4% | |
| Q3 2021 | -8.0% | -8.5% | -14.8% | |
| Q2 2021 | +2.6% | +4.3% | +4.9% | |
| Q1 2021 | +0.3% | +0.2% | +1.8% | |
| Q4 2020 | -3.4% | -5.4% | +1.0% | |
| Q3 2020 | +5.1% | +12.7% | +23.5% | |
| Q2 2020 | +8.4% | +10.3% | +4.1% | |
| Q1 2020 | +3.0% | +0.7% | +12.6% | |
| Q4 2019 | +5.7% | +10.9% | -27.6% | |
| Q3 2019 | +0.0% | +0.2% | +5.2% | |
| Q2 2019 | +2.8% | -2.3% | +4.7% | |
| Q1 2019 | -2.9% | -3.2% | -9.1% | |
| Q4 2018 | +2.6% | +2.3% | +4.3% | |
| Q3 2018 | +2.3% | +3.1% | -4.5% | |
| Q2 2018 | +3.0% | +1.3% | +6.1% | |
| Q1 2018 | -2.2% | -1.1% | +6.3% | |
| Q4 2017 | -1.9% | -1.5% | +6.2% | |
| Q3 2017 | +12.2% | +12.0% | +15.3% | |
| Q2 2017 | -2.0% | -1.6% | -11.9% | |
| Q1 2017 | -8.1% | -10.6% | -14.5% | |
| Q4 2016 | +1.8% | +4.1% | +5.7% | |
| Q3 2016 | +22.3% | +30.4% | +27.3% | |
| Q2 2016 | +4.0% | +5.8% | +10.2% | |
| Q1 2016 | +1.3% | — | — | |
| Q4 2015 | -2.4% | — | — | |
| Q3 2015 | +2.3% | — | — | |
| Q2 2015 | -8.6% | — | — | |
| Q1 2015 | +0.5% | — | — | |
| Q4 2014 | +1.0% | — | — | |
| Q3 2014 | +2.1% | — | — | |
| Q2 2014 | +0.7% | — | — | |
| Q1 2014 | -4.3% | — | — | |
| Q4 2013 | +9.5% | — | — | |
| Q3 2013 | -0.8% | — | — | |
| Q2 2013 | -1.0% | — | — | |
| Q1 2013 | -0.2% | — | — | |
| Q4 2012 | +2.1% | — | — | |
| Q3 2012 | -1.0% | — | — | |
| Q2 2012 | +6.0% | — | — | |
| Q1 2011 | -1.7% | — | — | |
| Q1 2012 | +1.9% | — | — | |
| Q4 2011 | -0.2% | — | — | |
| Q4 2010 | -0.2% | — | — | |
| Q3 2011 | -1.8% | — | — | |
| Q3 2010 | -1.8% | — | — | |
| Q2 2010 | -1.0% | — | — | |
| Q2 2011 | -1.0% | — | — | |
| Q1 2010 | -0.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro